Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey. Lynda El-Hassar , Ahmed Amara , Benoit Sanson , Oana Lacatus , Ahmed Amir Belhouchet , Madelon Kroneman , Kristl Claeys , Jean Philippe Plançon , Carmelo Rodolico , Guido Primiano , Francesca Trojsi , Massimiliano Filosto , Tiziana Enrica Mongini , Sara Bortolani , Mauro Monforte , Elena Carraro , Lorenzo Maggi , Federica Ricci , Vincenzo Silani , Daniele Orsucci , Alain Créange , Yann Péréon , Tanya Stojkovic , Nadine Anna Maria Elisabeth van der Beek , Antonio Toscano , Davide Pareyson , Shahram Attarian , Peter Y K Van den Bergh , Gauthier Remiche , Janneke G J Hoeijmakers , Umesh Badrising , Nicol C Voermans , Angela M Kaindl , Ulrike Schara-Schmidt , Benedikt Schoser , Elisabetta Gazzerro , Jana Haberlová , Stanislav Voháňka , Endre Pál , Maria Judit Molnar , Lea Leonardis , Ivailo L Tournev , Andrés Nascimento Osorio , Montse Olivé , Nuria Muelas , Jorge Alonso-Perez , Francesc Plá , Marianne de Visser , Gabriele Siciliano , Sabrina Sacconi Journal of neuromuscular diseases（2023）
摘要
TM has been essential during COVID-19, but its use still presents some limitations for NMD patients with cognitive deficits or for first-time diagnosis. Thus, TM should be used as complement to, rather than substitute, for face-to-face consultations.
更多 查看译文
关键词
Covid-19, Europe, Telemedicine, neuromuscular diseases
AI 理解论文
溯源树
样例
